Skip to main content

$0.022 (0%)

High

$0.02

Low

$0.02

Trades

56

Turnover

$22,520

Volume

1,033,118
30 June 2023 at 3:59pm
Register to track AT1 and receive email alerts.
Subject
AT1 Ann: Ceasing to be a substantial holder

AT1 Ann: Exclusive Agreement for HIV Testing Signed with Newfoundland

AT1 Ann: Change in substantial holding

AT1 Ann: Change in substantial holding

AT1 Ann: Change in substantial holding

AT1 Ann: Becoming a substantial holder

AT1 Ann: Investor Webinar Presentation

AT1 Ann: Quarterly Activity Report - 31 March 2023

AT1 Ann: Appendix 4C - 31 March 2023

AT1 Ann: Notification of cessation of securities - AT1

AT1 Ann: Change of Director's Interest Notice - J Keith

AT1 Ann: Change of Director's Interest Notice - C LaBelle

AT1 Ann: A$1.9m contract - South Africa HIV Self-Test private market

AT1 Ann: Ceasing to be a substantial holder

AT1 Ann: Significant Purchase Order for HIV Self-Tests for Europe

AT1 Ann: Atomo H1 FY23 Results Presentation

AT1 Ann: Investor Presentation

AT1 Ann: Appendix 4D and Half Year Financial Report

AT1 Ann: Change of Company Secretary

AT1 Ann: Quarterly Activity Report - 31 December 2022

AT1 Ann: Appendix 4C - 31 December 2022

AT1 Ann: Investor Webinar Presentation

AT1 Ann: Agreement for Rapid Pregnancy Tests Signed with NG Biotech

AT1 Ann: Initial Director's Interest Notice - Dr Walker

AT1 Ann: Appointment of Independent Non-Executive Director

AT1 Ann: Investor Webinar and Presentation

AT1 Ann: Change of Director's Interest Notice - John Kelly

AT1 Ann: Notification regarding unquoted securities - AT1

AT1 Ann: Results of 2022 Annual General Meeting

AT1 Ann: 2022 Annual General Meeting - MD & CEO's Address

AT1 Ann: 2022 Annual General Meeting - Chairman's Address

AT1 Ann: Quarterly Activity Report - 30 September 2022

AT1 Ann: Appendix 4C - 30 September 2022

AT1 Ann: 2022 Annual Report

AT1 Ann: 2022 Notice of Annual General Meeting

AT1 Ann: Atomo FY22 Results Presentation

AT1 Ann: Change of Director's Interest Notice - John Kelly

AT1 Ann: Notification regarding unquoted securities - AT1

AT1 Ann: Notification of cessation of securities - AT1

AT1 Ann: 2022 Appendix 4G and Corporate Governance Statement

AT1 Ann: Investor Webinar and Presentation

AT1 Ann: 2022 Appendix 4E and Annual Report

AT1 Ann: COVID RAT Supply Agreement signed with AllTest & TGA Update

AT1 Ann: Quarterly Activity Report - 30 June 2022

AT1 Ann: Appendix 4C - 30 June 2022

AT1 Ann: Change in substantial holding

AT1 Ann: Change in substantial holding

AT1 Ann: Cleansing Statement

AT1 Ann: Application for quotation of securities - AT1

AT1 Ann: Notification regarding unquoted securities - AT1

Register to track AT1 and receive email alerts.

Similar Companies

COH
CSX
CYC
EMV
IBX
IPD
MX1
RSH
SOM